|
23/01/2019
Chief executive and charity advocate torn between the left and the right hemisphere of the brain
|
|
23/01/2019
In theory, 2018 was a sellers’ market. At a macro-level there was plenty of dry powder looking for investment and a finite number of quality assets to invest it in, and as a result, multiples edged upwards. While it was a hot market, some high-profile companies up for sale have yet to transact
|
|
23/01/2019
The NHS is championing integrated care services to meet increasing health needs. Private providers should be playing an essential role – but do they risk being sidelined by the politics of privatisation? Marie Cahalane reports
|
|
23/01/2019
Home care is a sector that Darryn Gibson, chief executive of Healthcare at Home, believes “has not been made enough of”. After 10 months in the job, and with big plans on the horizon, Marie Cahalane catches up with him
|
|
23/01/2019
When it comes to health technology, the focus is often on fixing the symptoms of poor patient flow or scheduling, rather than addressing the root causes. However, a burgeoning market for operational technology may provide some welcome relief
|
|
23/01/2019
Marie Cahalane speaks to Octopus Healthcare chief executive Benjamin Davis as he reflects on a prosperous 2018 and considers what the next year holds
|
|
23/01/2019
The 10 Year NHS Plan hints at scrapping competitive tendering for independent sector providers. Rob Munro reflects on recent health service reforms and considers what it all means for the health investor community
|
|
23/01/2019
In December, private equity firm Apposite Capital invested in dentistry investment group Riverdale Healthcare, to part-fund Riverdale’s investment in a 10-practice dental group, Alpha Vitality. Rory Pope, partner at Apposite, tells HealthInvestor UK about the deal
|
